Research article Open access
Utility of cenegermin for the management of neurotrophic keratopathy after penetrating keratoplasty
Background: The study aimed to report the outcomes of patients treated with cenegermin 0.002% for neurotrophic keratopathy (NK) following penetrating keratoplasty (PK). Materials and methods: This retrospective case series included patients evaluated at a tertiary care hospital who completed an 8-week course of ceneger …